Atossa Therapeutics, Inc.

ATOS ·Healthcare, Drug Manufacturers - General, United States
Financial Statements › SEC Filings

SEC Filings

Form Filed Description
424B5 Feb 20, 2026 424B5
424B3 Feb 20, 2026 424B3
8-K Feb 17, 2026 8-K
8-K Feb 11, 2026 8-K
4/A Jan 30, 2026 4/A
8-K Jan 26, 2026 8-K
4 Jan 22, 2026 4
8-K Jan 9, 2026 8-K
8-K Jan 6, 2026 8-K
DEF 14A Dec 22, 2025 DEF 14A
PRE 14A Dec 12, 2025 PRE 14A
8-K Dec 4, 2025 8-K
10-Q Nov 12, 2025 10-Q
8-K Nov 12, 2025 8-K
4 Oct 21, 2025 4
3 Oct 21, 2025 3
8-K Oct 14, 2025 8-K
8-K Sep 26, 2025 8-K
8-K Sep 8, 2025 8-K
8-K Aug 21, 2025 8-K
10-Q Aug 12, 2025 10-Q
8-K Aug 12, 2025 8-K
SCHEDULE 13G/A Jul 29, 2025
SCHEDULE 13G/A Jul 16, 2025
4 May 22, 2025 4
← Newer Page 2 of 26 · 641 filings Older →